Neurimmune is a biopharmaceutical company developing antibody therapeutics.Its pipeline comprises drug candidates for Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis, fronto-temporal dementia, dementia with Lewy bodies as well as cardiomyopathy and type 2 diabetes. The company develops Reverse Translational Medicine technology platform that translates the genetic information obtained from white blood cells from elderly human donors into therapeutic antibodies.